Somewhat Positive Press Coverage Somewhat Unlikely to Impact Amedica (AMDA) Share Price

Share on StockTwits

News headlines about Amedica (NASDAQ:AMDA) have trended somewhat positive this week, Accern Sentiment reports. Accern ranks the sentiment of media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Amedica earned a news sentiment score of 0.06 on Accern’s scale. Accern also gave media coverage about the medical equipment provider an impact score of 46.1539795821639 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Amedica traded down $0.02, hitting $1.09, during trading hours on Thursday, Marketbeat.com reports. 112,334 shares of the stock traded hands, compared to its average volume of 635,225. Amedica has a one year low of $1.02 and a one year high of $6.96.

Several analysts recently issued reports on AMDA shares. Maxim Group reissued a “hold” rating on shares of Amedica in a research note on Tuesday, March 6th. ValuEngine raised Amedica from a “sell” rating to a “hold” rating in a research report on Wednesday, May 2nd.

About Amedica

Amedica Corporation, a biomaterial company, develops, manufactures, and commercializes a range of medical devices based on its silicon nitride technology platform in the United States, Europe, and South America. The company offers silicon nitride implants to surgeons and hospitals for use in cervical and thoracolumbar spine surgery under the Valeo brand.

Insider Buying and Selling by Quarter for Amedica (NASDAQ:AMDA)

Receive News & Ratings for Amedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedica and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Axiom Price Reaches $0.0078 on Exchanges
Axiom Price Reaches $0.0078 on Exchanges
Starta Hits 24-Hour Trading Volume of $0.00
Starta Hits 24-Hour Trading Volume of $0.00
Zacks: Brokerages Expect MTS Systems Co.  Will Announce Earnings of $0.63 Per Share
Zacks: Brokerages Expect MTS Systems Co. Will Announce Earnings of $0.63 Per Share
Obalon Therapeutics  Getting Somewhat Positive Media Coverage, Study Shows
Obalon Therapeutics Getting Somewhat Positive Media Coverage, Study Shows
Novus Therapeutics  Receives News Impact Score of 0.16
Novus Therapeutics Receives News Impact Score of 0.16
$4.68 Earnings Per Share Expected for Regeneron Pharmaceuticals Inc  This Quarter
$4.68 Earnings Per Share Expected for Regeneron Pharmaceuticals Inc This Quarter


Leave a Reply

 
© 2006-2018 Zolmax.